查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1566798

黏合剂屏障市场：按类型、应用和最终用户划分：2024-2033 年全球机会分析和产业预测

Adhesion Barrier Market By Type , By Application By End User : Global Opportunity Analysis and Industry Forecast, 2024-2033
出版日期: | 出版商: Allied Market Research | 英文 280 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2023年，黏合阻隔市场估值为7亿美元，预计2024年至2033年复合年增长率为7.8%，到2033年达到15亿美元。

沾黏屏障是医疗植入，可降低手术期间沾黏形成的风险。沾黏是手术后可能发生的组织和器官之间的异常连接。与沾黏相关的其他併发症包括肠阻塞、不孕症和慢性疼痛，这些併发症可能是由于癒合过程中组织相互沾黏引起的。为了防止粘连，粘连屏障在组织之间形成临时屏障。

全球黏连屏障市场的成长是由术后沾黏风险的惊人上升所推动的。根据一项研究，93% 的人在一次或多次腹部手术后会出现沾黏。此外，医疗保健专业人员对沾黏相关併发症的认识不断提高，以及创新黏连屏障产品的开拓也为全球市场的成长做出了重大贡献。研究人员和製造商正致力于开发由生物可吸收材料製成的黏合屏障，这些材料会逐渐被人体吸收，消除磨损程序。例如，领先的医疗解决方案供应商之一 Baxter AdvancedSurgery 开发了 Seprafilm 黏合屏障。此黏合屏障是一种无菌、可生物吸收、半透明、亲水性黏合屏障，由两种阴离子多醣、改质透明质酸钠和羧甲基纤维素组成。这种沾黏屏障可以显着降低沾黏的程度、发生率和严重程度。一项随机、前瞻性、双盲、多中心临床研究纳入了 183 名患有溃疡性大肠炎和息肉病的患者，他们接受了两阶段肠切除手术。其中，Seprafilm 沾黏屏障组中有 51% 的患者在术后 8 至 12 週内没有出现沾黏，而对照组则为 6%。此外，涉及黏合屏障的外科手术报销政策的增加正在推动其使用并促进全球市场的成长。然而，儘管正在进行研究，但还没有广泛用于预防术后沾黏的特定防沾黏屏障，这是市场的主要阻碍因素。相反，医疗保健专业人员正在将粘连屏障纳入手术方案中，以尽量减少粘连相关併发症的风险，预计这将成为全球需求的驱动力。此外，医学协会和医疗组织越来越多地倡议来传播意识并建立有关粘连预防和管理的指南，预计将为预测期内全球市场的扩张提供利润丰厚的机会。

全球黏合屏障市场按类型、应用、最终用户和地区细分。按类型划分，市场分为合成黏合屏障和天然黏合屏障。依用途分为普通/腹部外科、妇科外科、心血管外科、整形外科、神经外科等。依最终用户划分，可分为医院、专科诊所和门诊手术中心。按地区划分，分析涵盖北美、欧洲、亚太地区和拉丁美洲/中东/非洲。

主要发现

  • 按产品类型划分，合成黏合屏障细分市场将在 2023 年占据市场。
  • 根据申请，2023年一般外科/腹部外科业务成为主要股东。
  • 按最终用户划分，医院细分市场将在 2023 年获得最大份额。
  • 北美占有很大份额。

竞争格局

该报告可以定制（需要额外的费用和时间表）。

  • 按产品/细分市场细分
  • 按国家或地区进行的附加分析 – 市场规模和预测
  • 平均销售价格分析/价格分布分析
  • 扩大公司简介列表
  • 历史市场资料

目录

第一章简介

第 2 章执行摘要

第三章 市场状况

  • 市场定义和范围
  • 主要发现
    • 关键投资机会
    • 关键成功策略
  • 波特五力分析
  • 市场动态
    • 促进因素
    • 抑制因素
    • 机会

第四章黏合剂屏障市场：按类型

  • 市场概况
  • 合成黏合屏障
  • 天然黏合屏障

第五章黏合剂屏障市场：依应用分类

  • 市场概况
  • 普通外科/腹部外科
  • 妇科手术
  • 心血管外科
  • 整形外科
  • 神经外科
  • 其他的

第六章 黏合剂屏障市场：依最终用户分类

  • 市场概况
  • 医院
  • 专科诊所
  • 门诊手术中心

第七章黏合剂屏障市场：按地区

  • 市场概况
  • 北美洲
    • 主要市场趋势和机会
    • 美国黏合屏障市场
    • 加拿大黏合屏障市场
    • 墨西哥黏合剂屏障市场
  • 欧洲
    • 主要市场趋势和机会
    • 德国黏合剂屏障市场
    • 法国黏合屏障市场
    • 英国黏合屏障市场
    • 义大利黏合屏障市场
    • 西班牙黏合屏障市场
    • 其他欧洲黏合屏障市场
  • 亚太地区
    • 主要市场趋势和机会
    • 日本黏合屏障市场
    • 中国阻隔胶市场
    • 澳洲黏合屏障市场
    • 印度胶合剂屏障市场
    • 韩国黏合屏障市场
    • 其他亚太地区黏合剂屏障市场
  • 拉丁美洲/中东/非洲
    • 主要市场趋势和机会
    • 巴西黏合屏障市场
    • 沙乌地阿拉伯黏合剂屏障市场
    • 南非黏合屏障市场
    • 其他拉丁美洲/中东/非洲黏合屏障市场

第八章 竞争格局

  • 介绍
  • 关键成功策略
  • 10家主要企业产品图谱
  • 竞争对手仪表板
  • 竞争热图
  • 主要企业定位（2023年）

第九章 公司简介

  • Anika Therapeutics Inc.
  • Baxter International Inc.
  • Leader Biomedical
  • Betatech Medical
  • Fziomed, Inc.
  • Integra LifeSciences Holdings Corporation
  • Johnson And Johnson
  • CGBio Inc
  • Atrium Medical Corporation
  • Toray Industries Inc.
简介目录
Product Code: A09554

The adhesion barrier market was valued at $0.7 billion in 2023, and is projected to reach $1.5 billion by 2033, growing at a CAGR of 7.8% from 2024 to 2033.

Adhesion barrier is a medical implant that alleviates the risk of adhesion formation during surgeries. Adhesion is an abnormal connections between tissues or organs that can occur after surgery. Other complications associated with adhesion include bowel obstructions, infertility, and chronic pain, which can arise when tissues stick together while healing. To prevent them from sticking, adhesion barriers create a temporary barrier between the tissues.

The growth of the global adhesion barrier market is driven by alarming rise in the risk of post-surgical adhesions. According to a study, 93% of individuals develop adhesions following one or more abdominal operations. Moreover, increase in awareness among healthcare professionals about the complications associated with adhesions and development of innovative adhesion barrier products notably contribute toward the growth of the global market. Researchers and manufacturers are focusing on the development of adhesion barriers made from bioresorbable materials, which are absorbed by the body gradually, thereby eliminating the need for removal procedures. For instance, Baxter Advanced Surgery, one of the leading providers of healthcare solutions, developed Seprafilm adhesion barrier, which is a sterile, bioresorbable, translucent, and hydrophilic adhesion barrier composed of two anionic polysaccharides, modified sodium hyaluronate and carboxymethylcellulose. This adhesion barrier is capable of significantly reducing the extent, incidence, and severity of adhesions. A randomized, prospective, double-blinded, multicenter clinical study involved 183 patients suffering from ulcerative colitis and familiar polyposis who underwent 2-stage intestinal resection surgery. Among these, 51% of the patients of the Seprafilm Adhesion Barrier group were adhesion-free compared to 6% of control patients post at 8-12 weeks of surgery. Furthermore, increase in reimbursement policies for surgical procedures involving adhesion barriers encourage their use, which boosts the growth of the global market. However, there is no specific adhesion barrier that is widely used to prevent post-surgical adhesions, despite ongoing research, which acts as a key deterrent factor of the market. On the contrary, healthcare professionals are incorporating the use of adhesion barriers into their surgical protocols to minimize the risk of adhesion-related complications, which is expected to drive their demand globally. Moreover, rise in initiatives to spread awareness and establish guidelines regarding the prevention and management of adhesions by medical societies and healthcare organizations is anticipated to offer remunerative opportunities for the expansion of the global market during the forecast period.

The global adhesion barrier market is segmented into type, application, end user, and region. On the basis of type, the market is categorized into synthetic adhesion barrier, and natural adhesion barrier. Depending on application, it is segregated into general/abdominal surgeries, gynecological surgeries, cardiovascular surgeries, orthopedic surgeries, neurological surgeries, and others. By end user, it is fragmented into hospitals, Specialty Clinics, Ambulatory Surgical Centers. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

  • By product type, the synthetic adhesion barrier segment dominated the market, in terms of share in 2023.
  • Depending on application, the general/abdominal surgeries segment was the major shareholder in 2023.
  • On the basis of end user, the hospital segment acquired the maximum share in 2023.
  • North America holds a significant share of the market.

Competitive Landscape

The competitive analysis and profiles of the major players in the global adhesion barrier market include Anika Therapeutics Inc., Baxter International Inc., leader biomedical, Betatech Medical, Fziomed, Inc., Integra LifeSciences Holdings Corporation, Johnson & Johnson, CGBio Inc., Atrium Medical Corporation, and Toray Industry Inc. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships, which strengthen their foothold in the competitive market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Market share analysis of players by products/segments
  • Additional country or region analysis- market size and forecast
  • Average Selling Price Analysis / Price Point Analysis
  • Expanded list for Company Profiles
  • Historic market data

Key Market Segments

By Type

  • Synthetic Adhesion Barrier
  • Natural Adhesion Barrier

By Application

  • General/Abdominal Surgeries
  • Gynecological Surgeries
  • Cardiovascular Surgeries
  • Orthopedic Surgeries
  • Neurological Surgeries
  • Other Applications

By End User

  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players:

    • Anika Therapeutics Inc.
    • Baxter International Inc.
    • leader biomedical
    • Betatech Medical
    • fziomed, inc.
    • Integra LifeSciences Holdings Corporation
    • Johnson & Johnson
    • CGBio Inc
    • Atrium Medical Corporation
    • Toray Industries Inc.

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: ADHESION BARRIER MARKET, BY TYPE

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Type
  • 4.2. Synthetic Adhesion Barrier
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. Natural Adhesion Barrier
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country

CHAPTER 5: ADHESION BARRIER MARKET, BY APPLICATION

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By Application
  • 5.2. General/Abdominal Surgeries
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Gynecological Surgeries
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country
  • 5.4. Cardiovascular Surgeries
    • 5.4.1. Key Market Trends, Growth Factors and Opportunities
    • 5.4.2. Market Size and Forecast, By Region
    • 5.4.3. Market Share Analysis, By Country
  • 5.5. Orthopedic Surgeries
    • 5.5.1. Key Market Trends, Growth Factors and Opportunities
    • 5.5.2. Market Size and Forecast, By Region
    • 5.5.3. Market Share Analysis, By Country
  • 5.6. Neurological Surgeries
    • 5.6.1. Key Market Trends, Growth Factors and Opportunities
    • 5.6.2. Market Size and Forecast, By Region
    • 5.6.3. Market Share Analysis, By Country
  • 5.7. Other Applications
    • 5.7.1. Key Market Trends, Growth Factors and Opportunities
    • 5.7.2. Market Size and Forecast, By Region
    • 5.7.3. Market Share Analysis, By Country

CHAPTER 6: ADHESION BARRIER MARKET, BY END USER

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By End User
  • 6.2. Hospitals
    • 6.2.1. Key Market Trends, Growth Factors and Opportunities
    • 6.2.2. Market Size and Forecast, By Region
    • 6.2.3. Market Share Analysis, By Country
  • 6.3. Specialty Clinics
    • 6.3.1. Key Market Trends, Growth Factors and Opportunities
    • 6.3.2. Market Size and Forecast, By Region
    • 6.3.3. Market Share Analysis, By Country
  • 6.4. Ambulatory Surgical Centers
    • 6.4.1. Key Market Trends, Growth Factors and Opportunities
    • 6.4.2. Market Size and Forecast, By Region
    • 6.4.3. Market Share Analysis, By Country

CHAPTER 7: ADHESION BARRIER MARKET, BY REGION

  • 7.1. Market Overview
    • 7.1.1 Market Size and Forecast, By Region
  • 7.2. North America
    • 7.2.1. Key Market Trends and Opportunities
    • 7.2.2. Market Size and Forecast, By Type
    • 7.2.3. Market Size and Forecast, By Application
    • 7.2.4. Market Size and Forecast, By End User
    • 7.2.5. Market Size and Forecast, By Country
    • 7.2.6. U.S. Adhesion Barrier Market
      • 7.2.6.1. Market Size and Forecast, By Type
      • 7.2.6.2. Market Size and Forecast, By Application
      • 7.2.6.3. Market Size and Forecast, By End User
    • 7.2.7. Canada Adhesion Barrier Market
      • 7.2.7.1. Market Size and Forecast, By Type
      • 7.2.7.2. Market Size and Forecast, By Application
      • 7.2.7.3. Market Size and Forecast, By End User
    • 7.2.8. Mexico Adhesion Barrier Market
      • 7.2.8.1. Market Size and Forecast, By Type
      • 7.2.8.2. Market Size and Forecast, By Application
      • 7.2.8.3. Market Size and Forecast, By End User
  • 7.3. Europe
    • 7.3.1. Key Market Trends and Opportunities
    • 7.3.2. Market Size and Forecast, By Type
    • 7.3.3. Market Size and Forecast, By Application
    • 7.3.4. Market Size and Forecast, By End User
    • 7.3.5. Market Size and Forecast, By Country
    • 7.3.6. Germany Adhesion Barrier Market
      • 7.3.6.1. Market Size and Forecast, By Type
      • 7.3.6.2. Market Size and Forecast, By Application
      • 7.3.6.3. Market Size and Forecast, By End User
    • 7.3.7. France Adhesion Barrier Market
      • 7.3.7.1. Market Size and Forecast, By Type
      • 7.3.7.2. Market Size and Forecast, By Application
      • 7.3.7.3. Market Size and Forecast, By End User
    • 7.3.8. UK Adhesion Barrier Market
      • 7.3.8.1. Market Size and Forecast, By Type
      • 7.3.8.2. Market Size and Forecast, By Application
      • 7.3.8.3. Market Size and Forecast, By End User
    • 7.3.9. Italy Adhesion Barrier Market
      • 7.3.9.1. Market Size and Forecast, By Type
      • 7.3.9.2. Market Size and Forecast, By Application
      • 7.3.9.3. Market Size and Forecast, By End User
    • 7.3.10. Spain Adhesion Barrier Market
      • 7.3.10.1. Market Size and Forecast, By Type
      • 7.3.10.2. Market Size and Forecast, By Application
      • 7.3.10.3. Market Size and Forecast, By End User
    • 7.3.11. Rest of Europe Adhesion Barrier Market
      • 7.3.11.1. Market Size and Forecast, By Type
      • 7.3.11.2. Market Size and Forecast, By Application
      • 7.3.11.3. Market Size and Forecast, By End User
  • 7.4. Asia-Pacific
    • 7.4.1. Key Market Trends and Opportunities
    • 7.4.2. Market Size and Forecast, By Type
    • 7.4.3. Market Size and Forecast, By Application
    • 7.4.4. Market Size and Forecast, By End User
    • 7.4.5. Market Size and Forecast, By Country
    • 7.4.6. Japan Adhesion Barrier Market
      • 7.4.6.1. Market Size and Forecast, By Type
      • 7.4.6.2. Market Size and Forecast, By Application
      • 7.4.6.3. Market Size and Forecast, By End User
    • 7.4.7. China Adhesion Barrier Market
      • 7.4.7.1. Market Size and Forecast, By Type
      • 7.4.7.2. Market Size and Forecast, By Application
      • 7.4.7.3. Market Size and Forecast, By End User
    • 7.4.8. Australia Adhesion Barrier Market
      • 7.4.8.1. Market Size and Forecast, By Type
      • 7.4.8.2. Market Size and Forecast, By Application
      • 7.4.8.3. Market Size and Forecast, By End User
    • 7.4.9. India Adhesion Barrier Market
      • 7.4.9.1. Market Size and Forecast, By Type
      • 7.4.9.2. Market Size and Forecast, By Application
      • 7.4.9.3. Market Size and Forecast, By End User
    • 7.4.10. South Korea Adhesion Barrier Market
      • 7.4.10.1. Market Size and Forecast, By Type
      • 7.4.10.2. Market Size and Forecast, By Application
      • 7.4.10.3. Market Size and Forecast, By End User
    • 7.4.11. Rest of Asia-Pacific Adhesion Barrier Market
      • 7.4.11.1. Market Size and Forecast, By Type
      • 7.4.11.2. Market Size and Forecast, By Application
      • 7.4.11.3. Market Size and Forecast, By End User
  • 7.5. LAMEA
    • 7.5.1. Key Market Trends and Opportunities
    • 7.5.2. Market Size and Forecast, By Type
    • 7.5.3. Market Size and Forecast, By Application
    • 7.5.4. Market Size and Forecast, By End User
    • 7.5.5. Market Size and Forecast, By Country
    • 7.5.6. Brazil Adhesion Barrier Market
      • 7.5.6.1. Market Size and Forecast, By Type
      • 7.5.6.2. Market Size and Forecast, By Application
      • 7.5.6.3. Market Size and Forecast, By End User
    • 7.5.7. Saudi Arabia Adhesion Barrier Market
      • 7.5.7.1. Market Size and Forecast, By Type
      • 7.5.7.2. Market Size and Forecast, By Application
      • 7.5.7.3. Market Size and Forecast, By End User
    • 7.5.8. South Africa Adhesion Barrier Market
      • 7.5.8.1. Market Size and Forecast, By Type
      • 7.5.8.2. Market Size and Forecast, By Application
      • 7.5.8.3. Market Size and Forecast, By End User
    • 7.5.9. Rest of LAMEA Adhesion Barrier Market
      • 7.5.9.1. Market Size and Forecast, By Type
      • 7.5.9.2. Market Size and Forecast, By Application
      • 7.5.9.3. Market Size and Forecast, By End User

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top Winning Strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Top Player Positioning, 2023

CHAPTER 9: COMPANY PROFILES

  • 9.1. Anika Therapeutics Inc.
    • 9.1.1. Company Overview
    • 9.1.2. Key Executives
    • 9.1.3. Company Snapshot
    • 9.1.4. Operating Business Segments
    • 9.1.5. Product Portfolio
    • 9.1.6. Business Performance
    • 9.1.7. Key Strategic Moves and Developments
  • 9.2. Baxter International Inc.
    • 9.2.1. Company Overview
    • 9.2.2. Key Executives
    • 9.2.3. Company Snapshot
    • 9.2.4. Operating Business Segments
    • 9.2.5. Product Portfolio
    • 9.2.6. Business Performance
    • 9.2.7. Key Strategic Moves and Developments
  • 9.3. Leader Biomedical
    • 9.3.1. Company Overview
    • 9.3.2. Key Executives
    • 9.3.3. Company Snapshot
    • 9.3.4. Operating Business Segments
    • 9.3.5. Product Portfolio
    • 9.3.6. Business Performance
    • 9.3.7. Key Strategic Moves and Developments
  • 9.4. Betatech Medical
    • 9.4.1. Company Overview
    • 9.4.2. Key Executives
    • 9.4.3. Company Snapshot
    • 9.4.4. Operating Business Segments
    • 9.4.5. Product Portfolio
    • 9.4.6. Business Performance
    • 9.4.7. Key Strategic Moves and Developments
  • 9.5. Fziomed, Inc.
    • 9.5.1. Company Overview
    • 9.5.2. Key Executives
    • 9.5.3. Company Snapshot
    • 9.5.4. Operating Business Segments
    • 9.5.5. Product Portfolio
    • 9.5.6. Business Performance
    • 9.5.7. Key Strategic Moves and Developments
  • 9.6. Integra LifeSciences Holdings Corporation
    • 9.6.1. Company Overview
    • 9.6.2. Key Executives
    • 9.6.3. Company Snapshot
    • 9.6.4. Operating Business Segments
    • 9.6.5. Product Portfolio
    • 9.6.6. Business Performance
    • 9.6.7. Key Strategic Moves and Developments
  • 9.7. Johnson And Johnson
    • 9.7.1. Company Overview
    • 9.7.2. Key Executives
    • 9.7.3. Company Snapshot
    • 9.7.4. Operating Business Segments
    • 9.7.5. Product Portfolio
    • 9.7.6. Business Performance
    • 9.7.7. Key Strategic Moves and Developments
  • 9.8. CGBio Inc
    • 9.8.1. Company Overview
    • 9.8.2. Key Executives
    • 9.8.3. Company Snapshot
    • 9.8.4. Operating Business Segments
    • 9.8.5. Product Portfolio
    • 9.8.6. Business Performance
    • 9.8.7. Key Strategic Moves and Developments
  • 9.9. Atrium Medical Corporation
    • 9.9.1. Company Overview
    • 9.9.2. Key Executives
    • 9.9.3. Company Snapshot
    • 9.9.4. Operating Business Segments
    • 9.9.5. Product Portfolio
    • 9.9.6. Business Performance
    • 9.9.7. Key Strategic Moves and Developments
  • 9.10. Toray Industries Inc.
    • 9.10.1. Company Overview
    • 9.10.2. Key Executives
    • 9.10.3. Company Snapshot
    • 9.10.4. Operating Business Segments
    • 9.10.5. Product Portfolio
    • 9.10.6. Business Performance
    • 9.10.7. Key Strategic Moves and Developments